Home › Asset managers › Compare 2025-2026 › Vanguard vs John Hancock
Vanguard 2025-2026 · John Hancock 2025-2026 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 24,250 | 20,523 | 1,067 | 2,660 | 95.1% | 91.3% |
| Board proposals | 19,946 | 16,805 | 965 | 2,176 | 94.6% | 90.9% |
| E&S shareholder proposals | 163 | 81 | 5 | 77 | 94.2% | 82.9% |
| Other items | 4,141 | 3,637 | 97 | 407 | 97.4% | 93.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
2,176 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Vanguard | John Hancock |
|---|---|---|---|---|---|---|
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT JOSUA MALHERBE AS DIRECTOR Director Elections |
Board | Not determined | FOR 6 funds |
Split 3 FOR, 1 AGAINST |
| COMPAGNIE FINANCIERE RICHEMONT SA | September 10, 2025 | REELECT NIKESH ARORA AS DIRECTOR Director Elections |
Board | Not determined | Split 1 FOR, 5 AGAINST |
FOR 4 funds |
| COMPASS DIVERSIFIED HOLDINGS | May 21, 2026 | To ratify the appointment of Grant Thornton LLP to serve as the independent auditor for Compass Diversified Holdings and Compass Group Diversified Holdings LLC for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 7 FOR, 1 AGAINST |
FOR 3 funds |
| COMPASS MINERALS INTERNATIONAL, INC. | March 5, 2026 | Approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
AGAINST 6 funds |
| COMSTOCK INC. | May 28, 2026 | Approve the Comstock Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| CONCENTRIX CORPORATION | March 25, 2026 | Approval of an amendment to the Company's 2020 Stock Incentive Plan to increase the number of shares available for issuance. Compensation |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 5 funds |
| CONCENTRIX CORPORATION | March 25, 2026 | Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026; Audit-related |
Board | For | Split 18 FOR, 3 AGAINST |
FOR 5 funds |
| CONDUENT INCORPORATED | May 14, 2026 | Approval, on an advisory basis, of the 2025 compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 13 funds |
Split 5 FOR, 1 AGAINST |
| CONFLUENT, INC. | February 12, 2026 | To approve, on a non-binding, advisory basis, the compensation that will or may become payable by Confluent, Inc. to its named executive officers in connection with the merger contemplated by the merger agreement. Say-on-Pay |
Board | For | Split 17 FOR, 3 AGAINST |
FOR 5 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve an amendment and restatement of the Company's 2021 Stock Incentive Plan. Compensation |
Board | For | Split 11 FOR, 2 AGAINST |
FOR 3 funds |
| CONSENSUS CLOUD SOLUTIONS, INC. | June 10, 2026 | To approve, on an advisory basis, the appointment of Deloitte & Touche, LLP as the Company's independent registered public accounting firm for 2026. Audit-related |
Board | For | Split 11 FOR, 2 AGAINST |
FOR 3 funds |
| CONSOLIDATED WATER CO. LTD. | June 1, 2026 | The approval of a Special Resolution, attached as Exhibit B to the Proxy Statement, adopting an amendment to the Company's Amended and Restated Memorandum of Association relating to the increase of the share capital of the Company approved by Ordinary Resolution in Proposal 3. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 2 funds |
| CONSOLIDATED WATER CO. LTD. | June 1, 2026 | The approval of an Ordinary Resolution, attached as Exhibit A to the Proxy Statement, authorizing an increase of the share capital of the Company from (i) CI$12.5 million divided into 24,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50 each to (ii) CI$25 million divided into 49,800,000 Ordinary Shares of par value CI$0.50 each and 200,000 Redeemable Preference Shares of par value CI$0.50. Capital Structure |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 2 funds |
| CONSTELLATION BRANDS, INC. | July 15, 2025 | To approve, by an advisory vote, the compensation of the Company's named executive officers as disclosed in the Proxy Statement. Say-on-Pay |
Board | For | Split 32 FOR, 3 AGAINST |
FOR 8 funds |
| CONSTRUCTION PARTNERS INC | March 24, 2026 | Proposal to elect two Class II directors to serve for a three-year term expiring at the 2029 annual meeting of stockholders. Craig Jennings Director Elections |
Board | For | Split 1 FOR, 12 WITHHOLD |
WITHHOLD 5 funds |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | 2026 APPLICATION FOR COMPREHENSIVE CREDIT LINE TO FINANCIAL INSTITUTIONS Extraordinary Transactions |
Board | For | FOR 4 funds |
Split 6 FOR, 1 AGAINST |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | CHANGE OF THE PURPOSE OF THE A-SHARE RAISED FUNDS Capital Structure |
Board | For | FOR 4 funds |
Split 2 FOR, 5 AGAINST |
| CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED | April 3, 2026 | GENERAL AUTHORIZATION FOR THE ADDITIONAL H-SHARE OFFERING Capital Structure |
Board | For | FOR 4 funds |
Split 6 FOR, 1 AGAINST |
| CONTINENTAL AG | April 30, 2026 | REELECT SATISH KHATU TO THE SUPERVISORY BOARD Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 1 AGAINST |
| COOPER COMPANIES INC | April 7, 2026 | Approve, on a non-binding, advisory basis, the compensation of our Named Executive Officers. Say-on-Pay |
Board | For | Split 23 FOR, 6 AGAINST |
FOR 13 funds |
| COOPER-STANDARD HOLDINGS INC. | May 14, 2026 | Ratification of Appointment of Independent Registered Public Accounting Firm. Audit-related |
Board | For | Split 10 FOR, 2 AGAINST |
FOR 4 funds |
| CORBUS PHARMACEUTICALS HOLDINGS, INC. | May 13, 2026 | Approval of an amendment to the Corbus Pharmaceuticals Holdings, Inc. 2024 Equity Compensation Plan to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares to 5,000,000 shares. Compensation |
Board | For | Split 4 FOR, 1 AGAINST |
AGAINST 1 fund |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan. Compensation |
Board | For | Split 14 FOR, 12 AGAINST |
AGAINST 2 funds |
| CORCEPT THERAPEUTICS INCORPORATED | May 21, 2026 | To approve, on an advisory basis, the compensation of the company's named executive officers as disclosed in the accompanying proxy statement. Say-on-Pay |
Board | For | Split 25 FOR, 5 AGAINST |
FOR 4 funds |
| CORE NATURAL RESOURCES, INC. | April 30, 2026 | Approval, on an Advisory Basis, of the Compensation Paid to Core Natural Resources, Inc.'s Named Executive Officers in 2025. Say-on-Pay |
Board | For | Split 20 FOR, 5 AGAINST |
FOR 9 funds |
| CORE SCIENTIFIC, INC. | May 12, 2026 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 10 FOR, 12 AGAINST |
Split 1 FOR, 6 AGAINST |
| CORPAY, INC. | May 7, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 27 FOR, 10 AGAINST |
Split 2 FOR, 11 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Annabelle Bexiga Director Elections |
Board | For | FOR 32 funds |
Split 2 FOR, 8 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Hala G. Moddelmog Director Elections |
Board | For | FOR 22 funds |
Split 2 FOR, 8 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Joseph W. Farrelly Director Elections |
Board | For | FOR 32 funds |
Split 2 FOR, 8 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Rahul Gupta Director Elections |
Board | For | FOR 32 funds |
Split 8 FOR, 2 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Steven T. Stull Director Elections |
Board | For | FOR 32 funds |
Split 2 FOR, 8 AGAINST |
| CORPAY, INC. | May 7, 2026 | Elect Directors nominated by the Board of Directors for a one-year term: Thomas M. Hagerty Director Elections |
Board | For | FOR 32 funds |
Split 2 FOR, 8 AGAINST |
| CORPAY, INC. | May 7, 2026 | Ratify the re-appointment of Ernst & Young LLP as Corpay's independent public accounting firm for 2026. Audit-related |
Board | For | Split 22 FOR, 9 AGAINST |
FOR 10 funds |
| CORSAIR GAMING, INC. | June 16, 2026 | To ratify the selection, by the audit committee of our Board of Directors, of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026. Audit-related |
Board | For | Split 16 FOR, 3 AGAINST |
FOR 3 funds |
| COSTAR GROUP, INC. | June 23, 2026 | Proposal to approve, on an advisory basis, the Company's executive compensation. Say-on-Pay |
Board | For | Split 33 FOR, 8 AGAINST |
Split 7 FOR, 2 AGAINST |
| COSTCO WHOLESALE CORPORATION | January 15, 2026 | Approval, on an advisory basis, of executive compensation. Say-on-Pay |
Board | For | Split 39 FOR, 1 AGAINST |
Split 7 FOR, 2 AGAINST |
| COTERRA ENERGY INC. | May 4, 2026 | To approve, on a non-binding advisory basis, the compensation that may be paid or become payable to Coterra's named executive officers that is based on or otherwise relates to the merger (the ''Advisory Compensation Proposal''); and Say-on-Pay |
Board | For | Split 31 FOR, 9 AGAINST |
FOR 10 funds |
| COUPANG, INC. | June 11, 2026 | Election of Director: Director withdrawn Director Elections |
Board | For | Split 4 FOR, 2 ABSTAIN |
ABSTAIN 3 funds |
| COURSERA, INC. | June 10, 2026 | Approval, on a non-binding advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 19 FOR, 2 AGAINST |
FOR 5 funds |
| CRANE NXT, CO. | May 21, 2026 | Ratification of the selection of Deloitte & Touche LLP as the Company's independent auditors for 2026. Audit-related |
Board | For | Split 17 FOR, 9 AGAINST |
FOR 4 funds |
| CREDICORP LTD. | March 31, 2026 | Appointment of the external auditors of Credicorp to perform such services for the 2026 financial year and delegation of the power to set and approve fees for such audit services to the Board of Directors (for further delegation to the Audit Committee thereof) (See Appendix 4). Audit-related |
Board | For | Split 4 FOR, 2 AGAINST |
FOR 6 funds |
| CREDICORP LTD. | March 31, 2026 | Election of Director: Luis Romero Belismelis Director Elections |
Board | For | FOR 2 funds |
Split 4 FOR, 2 AGAINST |
| CREDICORP LTD. | March 31, 2026 | Election of Director: Raimundo Morales Dasso Director Elections |
Board | For | FOR 2 funds |
Split 4 FOR, 2 AGAINST |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | Split 18 FOR, 6 AGAINST |
AGAINST 4 funds |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Election of Directors: Glenda J. Flanagan Director Elections |
Board | For | FOR 14 funds |
Split 2 FOR, 1 WITHHOLD |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Election of Directors: Scott J. Vassalluzzo Director Elections |
Board | For | FOR 14 funds |
Split 2 FOR, 1 WITHHOLD |
| CREDIT ACCEPTANCE CORPORATION | June 10, 2026 | Election of Directors: Thomas N. Tryforos Director Elections |
Board | For | FOR 14 funds |
Split 2 FOR, 1 WITHHOLD |
| CRESCENT BIOPHARMA, INC. | June 2, 2026 | To approve, on a non-binding, advisory basis, the compensation of Crescent Biopharma, Inc.'s named executive officers. Say-on-Pay |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 3 funds |
| CRH PLC | May 7, 2026 | Disapplication of Pre-emption Rights Capital Structure |
Board | For | Split 43 FOR, 1 AGAINST |
FOR 9 funds |
| CRICUT, INC. | June 3, 2026 | To approve, by non-binding vote, named executive officer compensation. Say-on-Pay |
Board | For | Split 8 FOR, 8 AGAINST |
AGAINST 6 funds |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; Say-on-Pay |
Board | For | Split 18 FOR, 2 AGAINST |
FOR 8 funds |
| CRINETICS PHARMACEUTICALS, INC. | June 18, 2026 | To elect three directors to serve as Class II directors for a three-year term to expire at the 2029 annual meeting of shareholders; Caren Deardorf Director Elections |
Board | For | FOR 13 funds |
Split 2 FOR, 1 WITHHOLD |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan. Compensation |
Board | For | FOR 8 funds |
Split 1 FOR, 3 AGAINST |
| CRISPR THERAPEUTICS AG | June 4, 2026 | Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay |
Board | For | Split 13 FOR, 1 AGAINST |
Split 1 FOR, 5 AGAINST |
| CROCS, INC. | June 9, 2026 | An advisory vote to approve the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 26 FOR, 8 AGAINST |
FOR 7 funds |
| CROCS, INC. | June 9, 2026 | Approval of the Crocs, Inc. 2026 Equity Incentive Plan. Compensation |
Board | For | Split 28 FOR, 1 AGAINST |
AGAINST 5 funds |
| CROWN CASTLE INC. | May 20, 2026 | The non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 40 FOR, 2 AGAINST |
Split 15 FOR, 1 AGAINST |
| CRYOPORT, INC. | June 5, 2026 | To approve an amendment to the Cryoport, Inc. 2018 Omnibus Equity Incentive Plan to increase the number of authorized shares for issuance thereunder from 10,350,000 to 14,625,000; Compensation |
Board | For | Split 11 FOR, 2 AGAINST |
AGAINST 3 funds |
| CSG SYSTEMS INTERNATIONAL, INC. | January 30, 2026 | To approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to the named executive officers of CSG in connection with the consummation of the merger; and Say-on-Pay |
Board | For | Split 23 FOR, 4 AGAINST |
FOR 5 funds |
| CURIOSITYSTREAM INC. | May 20, 2026 | To approve an amendment to the CuriosityStream Inc. 2020 Omnibus Incentive Plan (the Plan) to increase the number of shares of Common Stock authorized for issuance under the Plan from 10,725,000 shares of Common Stock to 11,725,000 shares of Common Stock. Compensation |
Board | For | Split 8 FOR, 2 AGAINST |
AGAINST 3 funds |
| CURIOSITYSTREAM INC. | May 20, 2026 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers as disclosed in the Proxy Statement. Compensation |
Board | For | Split 5 FOR, 7 AGAINST |
AGAINST 2 funds |
| CUSHMAN & WAKEFIELD LTD. | May 14, 2026 | Appointment of KPMG LLP as independent auditor for the fiscal year ending December 31, 2026, and authorization of the Audit Committee to set the independent auditor's remuneration. Audit-related |
Board | For | Split 27 FOR, 3 AGAINST |
FOR 5 funds |
| CUSHMAN & WAKEFIELD PLC | October 16, 2025 | To approve Advisory Resolution No. 3, Bye-law Provision: Authorization of Preference Shares, a proposal seeking our Shareholders' views, on a non-binding, advisory basis, on the authorization of preference shares in the New Cushman & Wakefield Bye-laws. Corporate Governance |
Board | For | Split 19 FOR, 1 AGAINST |
FOR 4 funds |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve a non-binding advisory resolution on named executive officer compensation. Say-on-Pay |
Board | For | Split 23 FOR, 2 AGAINST |
AGAINST 6 funds |
| CUSTOMERS BANCORP, INC. | May 26, 2026 | To approve an amendment to the Company's 2019 Stock Incentive Plan. Compensation |
Board | For | Split 20 FOR, 1 AGAINST |
AGAINST 4 funds |
| CVR ENERGY, INC. | June 4, 2026 | To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay |
Board | For | Split 26 FOR, 2 AGAINST |
AGAINST 6 funds |
| CYTOMX THERAPEUTICS, INC. | June 17, 2026 | To approve an amendment to our Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock from 300,000,000 shares to 600,000,000 shares; Capital Structure |
Board | For | Split 7 FOR, 2 AGAINST |
FOR 1 fund |
| D'IETEREN GROUP | May 28, 2026 | Reelect Diligencia Consult SRL, Represented by Diane Govaerts, as Independent Director Director Elections |
Board | For | FOR 7 funds |
Split 2 FOR, 3 AGAINST |
| DAIMLER TRUCK HOLDING AG | May 6, 2026 | Reelect Harald Wilhelm to the Supervisory Board Director Elections |
Board | For | Split 1 FOR, 8 AGAINST |
Split 2 FOR, 1 AGAINST |
| DAIMLER TRUCK HOLDING AG | May 6, 2026 | Reelect Marie Wieck to the Supervisory Board Director Elections |
Board | For | FOR 9 funds |
Split 2 FOR, 1 AGAINST |
| DANA INCORPORATED | April 22, 2026 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm. Audit-related |
Board | For | Split 21 FOR, 6 AGAINST |
FOR 4 funds |
| DATADOG, INC. | April 21, 2026 | To approve the redomiciliation of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | Split 12 FOR, 20 AGAINST |
AGAINST 7 funds |
| DAUCH CORPORATION | April 30, 2026 | Ratification of the appointment of Deloitte and Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 20 FOR, 4 AGAINST |
FOR 4 funds |
| DAVITA INC. | June 4, 2026 | To approve, on an advisory basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | Split 23 FOR, 7 AGAINST |
FOR 9 funds |
| DAYFORCE, INC. | November 12, 2025 | A proposal to adopt the Agreement and Plan of Merger, dated as of August 20, 2025 (the "merger agreement"), by and among Dayforce, Inc. ("Dayforce"), Dawn Bidco, LLC and Dawn Acquisition Merger Sub, Inc. Extraordinary Transactions |
Board | For | FOR 20 funds |
Split 6 FOR, 2 AGAINST |
| DAYFORCE, INC. | November 12, 2025 | A proposal to approve, on an advisory (non-binding) basis, the compensation that may be paid or become payable to Dayforce's named executive officers in connection with the transactions contemplated by the merger agreement, including consummation of the merger. Say-on-Pay |
Board | For | Split 22 FOR, 2 AGAINST |
Split 9 FOR, 2 AGAINST |
| DEERE & COMPANY | February 25, 2026 | Ratification of the appointment of Deloitte & Touche LLP as Deere's independent registered public accounting firm for fiscal 2026 Audit-related |
Board | For | Split 35 FOR, 1 AGAINST |
FOR 5 funds |
| DEFINITIVE HEALTHCARE CORP. | June 4, 2026 | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers, as disclosed in this Proxy Statement. Say-on-Pay |
Board | For | Split 6 FOR, 5 AGAINST |
AGAINST 1 fund |
| DELCATH SYSTEMS, INC. | May 13, 2026 | To approve an amendment of the Company's 2020 Omnibus Equity Incentive Plan to increase by 1,800,000 the number of shares of common stock, $0.01 par value per share (''Common Stock'') available thereunder; Compensation |
Board | For | Split 6 FOR, 1 AGAINST |
AGAINST 3 funds |
| DELCATH SYSTEMS, INC. | May 13, 2026 | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the accompanying proxy statement (''Proxy Statement''). Say-on-Pay |
Board | For | Split 9 FOR, 1 AGAINST |
AGAINST 5 funds |
| DELIVERY HERO SE | June 23, 2026 | ELECT ROGER RABALAIS TO THE SUPERVISORY BOARD Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 3 funds |
| DELIVERY HERO SE | June 23, 2026 | ELECT SCOTT FERGUSON TO THE SUPERVISORY BOARD Director Elections |
Board | For | Split 6 FOR, 1 AGAINST |
FOR 3 funds |
| DELL TECHNOLOGIES INC. | June 25, 2026 | Approval of the Redomestication Proposal providing for the redomestication of Dell Technologies Inc. from Delaware to Texas by conversion as disclosed in the proxy statement Extraordinary Transactions |
Board | For | Split 18 FOR, 16 AGAINST |
Split 1 FOR, 7 AGAINST |
| DELL TECHNOLOGIES INC. | June 25, 2026 | Approval, on a non-binding, advisory basis, of the compensation of Dell Technologies Inc.'s named executive officers as disclosed in the proxy statement Say-on-Pay |
Board | For | Split 22 FOR, 18 AGAINST |
Split 2 FOR, 9 AGAINST |
| DELUXE CORPORATION | April 23, 2026 | Approval of Amendment No. 3 to the Deluxe Corporation 2022 Stock Incentive Plan. Compensation |
Board | For | Split 15 FOR, 4 AGAINST |
FOR 4 funds |
| DENTSPLY SIRONA INC. | June 2, 2026 | Approval of Amendment No. 2 to the 2024 Omnibus Incentive Plan to increase the number of shares of the Company's Common Stock issuable under such Plan. Compensation |
Board | For | Split 21 FOR, 5 AGAINST |
FOR 4 funds |
| DENTSPLY SIRONA INC. | June 2, 2026 | Approval, by non-binding vote, of the Company's executive compensation for 2025. Say-on-Pay |
Board | For | Split 26 FOR, 5 AGAINST |
FOR 6 funds |
| DENTSPLY SIRONA INC. | June 2, 2026 | Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accountants for 2026. Audit-related |
Board | For | Split 21 FOR, 5 AGAINST |
FOR 4 funds |
| DESIGNER BRANDS INC. | June 17, 2026 | Ratification of the appointment of Deloitte & Touche LLP as our independent registered accounting firm for the fiscal year ending January 30, 2027. Audit-related |
Board | For | Split 8 FOR, 2 AGAINST |
FOR 4 funds |
| DESTINATION XL GROUP, INC. | August 7, 2025 | To approve, on an advisory basis, named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
Split 4 FOR, 1 AGAINST |
| DEXCOM, INC. | May 27, 2026 | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2025. Say-on-Pay |
Board | For | Split 32 FOR, 10 AGAINST |
FOR 9 funds |
| DHI GROUP, INC. | May 15, 2026 | Approval of the Second Amendment to the DHI Group, Inc. 2022 Omnibus Equity Award Plan, as amended and restated Compensation |
Board | For | Split 3 FOR, 1 AGAINST |
FOR 1 fund |
| DIAMEDICA THERAPEUTICS INC. | May 20, 2026 | To approve an amendment and restatement of the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan. Compensation |
Board | For | Split 4 FOR, 1 AGAINST |
FOR 3 funds |
| DIAMONDBACK ENERGY, INC. | May 20, 2026 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | Split 32 FOR, 9 AGAINST |
FOR 14 funds |
| DICK'S SPORTING GOODS, INC. | June 10, 2026 | Non-binding advisory vote to approve compensation of named executive officers, as disclosed in the Company's 2026 proxy statement. Say-on-Pay |
Board | For | Split 43 FOR, 10 AGAINST |
FOR 8 funds |
| DIEBOLD NIXDORF, INCORPORATED | May 22, 2026 | To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the year ending December 31, 2026. Audit-related |
Board | For | Split 14 FOR, 2 AGAINST |
FOR 4 funds |
| DIGITAL REALTY TRUST, INC. | May 29, 2026 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers, as more fully described in the accompanying Proxy Statement (Say-on-Pay). Say-on-Pay |
Board | For | Split 29 FOR, 7 AGAINST |
FOR 15 funds |
| DIGITALBRIDGE GROUP, INC. | May 28, 2026 | To approve, on a non-binding, advisory basis, named executive officer compensation Say-on-Pay |
Board | For | Split 17 FOR, 1 AGAINST |
AGAINST 6 funds |
| DILLARD'S, INC. | August 19, 2025 | To approve the reincorporation of the Company from the State of Delaware to the State of Texas by conversion. Extraordinary Transactions |
Board | For | Split 3 FOR, 16 AGAINST |
AGAINST 4 funds |
← Previous Page 6 of 22 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 25, 2026 from SEC Form N-PX filings.